Central Garden & Pet Company (CENT) has long been a go-to name for everyday pet owners and gardeners stocking up on everything from dog food and bird seed to fertilizers and lawn tools. As a consumer products powerhouse in these niches, the company rode the pet adoption boom during the pandemic but has faced some post-COVID normalization lately. Diving into the fundamentals, we’ve seen steady top-line growth over the years, though recent dips and insider selling warrant a closer look before jumping in as a retail investor.

Revenue Growth: A Solid Climb with Recent Soft Spots

Revenue tells a story of expansion followed by stabilization. From $1.83 billion in 2016, it climbed impressively to $3.34 billion in 2022—a whopping 83% increase over six years, fueled by pandemic-driven pet spending surges and strategic acquisitions like the 2018 purchase of Nylabone and 2021’s Ferti-Lome deals. This per-share revenue metric jumped from $29.88 to $50.19, highlighting efficient scaling even as shares outstanding hovered around 65-70 million. Why care about revenue per share? It strips out dilution effects, giving a cleaner view of growth benefiting actual shareholders.

But 2023 and 2024 brought a slowdown: revenue dipped 1% to $3.31 billion in 2023, then another 3% to $3.20 billion in 2024. Employee count mirrors this, dropping from 7,000 in 2022 to 6,450 in 2024 (an 8% cut), yet revenue per employee rose to $496,000—a sign of operational efficiency amid cost controls. Analyst forecasts paint a brighter path ahead: revenue holding steady at $3.13 billion in 2025 before ticking up 1% annually through 2028 to $3.31 billion. This suggests a maturing business leaning on brand loyalty rather than explosive growth, correlating with stabilizing pet ownership trends post-2022.

Stock price action ties in here—lows and highs expanded from $9-$27 in 2016 to $28-$41 in 2025, roughly a 200%+ range expansion at the bottom end, outpacing revenue growth early on but lagging lately as revenue softened.

Profitability: Margins Under Pressure, But Recovery in Sight

Earnings paint a volatile but upward-trending picture. Net income peaked at $152 million in both 2021 and 2022 (up 26% from 2020’s $122 million), driven by EBT margins around 6%, which are crucial as they show pre-tax operational health before one-offs like tax changes hit. Gross margins held steady at 29-30% through most years, dipping to 28.6% in 2023 amid supply chain costs but rebounding to 31.9% in 2025 estimates— a key positive, as healthier gross margins signal pricing power in commoditized pet/garden segments.

ROE (return on equity) followed suit, hitting 15.6% in 2018 before settling at 7.2% in 2024, still respectable for a steady grower. The 2022 outlier? Negative free cash flow per share at -$2.24 due to heavy capex ($115 million, or 173% more than prior year), likely for distribution upgrades post-acquisitions. Fast-forward, FCF per share roared back to $5.35 in 2024 from $5.00 in 2023—a 7% gain—bolstering the balance sheet.

Looking forward, analysts expect net income to surge 50% to $164 million in 2025 from 2024’s $109 million, with EPS climbing from $1.64 to $2.58 (57% jump). By 2028, EPS could reach $3.18, implying sustained margin expansion if revenue guidance holds. This optimism correlates with improving EBT margins to 6.9% in 2025, potentially from efficiency gains.

Balance Sheet: Manageable Debt, Growing Equity

Shareholders’ equity has been a bright spot, ballooning 181% from $555 million in 2016 to $1.56 billion in 2024, boosting book value per share from $9.06 to $23.70 (162% rise). Total debt stabilized around $1.19 billion lately (flat since 2021’s jump from $694 million, or 71% increase post-borrowing for growth). Net debt trimmed to $422 million in 2024 from $994 million in 2022 (57% drop), thanks to FCF generation—vital for reducing leverage risk in a rising-rate world.

ROIC (return on invested capital) at 5.9% in 2024 lags earlier 11.2% peaks but is forecasted to rebound to 8.3%, underscoring efficient capital use ahead. Working capital swelled to $1.37 billion in 2024 (10% YoY growth), providing a buffer for inventory-heavy ops like pet food.

Valuation: Reasonable Multiples with Upside Potential

At recent levels, CENT trades at a forward PE around 13-14x based on 2025 EPS estimates, down from 22x trailing—cheaper than the 25-27x peaks in 2016-17 when growth was nascent. PS ratio sits low at 0.66x forward sales, and PB at 1.3x, both attractive for a company with 10%+ forecasted EPS growth. EV/FCF improved to 8x in 2024 from negative territory in 2022, signaling cash flow normalization.

Compared to stock price evolution, shares traded at 12x PE in 2022 amid peak revenue, but multiples compressed as earnings softened—now aligning better with fundamentals. Analyst price targets reflect this: the average implies about 32% upside from recent closes, with the high end at 34% and low at 13% downside. Not screaming buy, but consensus leans bullish, pricing in those EPS ramps.

Insider Activity: All Sells, No Buys—A Caution Flag

Insider transactions over the past year (through early 2026) show zero buys and $7.9 million in sells across 9 transactions. The Chairman/10% owner dumped big: 100,000 shares in May 2025 ($3.2 million), 103,125 in August ($3.4 million), totaling over $6.2 million from one pocket. Other execs and directors chipped in smaller sales, like the President of Pet Consumer Products’ 9,375 shares. No buys total? That’s unusual for a turnaround story and correlates with the 2024 earnings dip—insiders might be cashing out at highs (2025 highs ~41) amid flat revenue. Watch for 10b5-1 plans, but it tempers enthusiasm.

Tying It to Broader Events and Stock Trajectory

CENT benefited hugely from the 2020-2022 pet boom—U.S. pet spending hit record $136 billion in 2022 per APPA data—pushing shares from 2020 lows (~19) to 2021 highs (49), a 163% swing. Garden segment shone too, with lawn care up post-lockdowns. Headwinds? Inflation squeezed margins in 2023, plus a softer housing market hurting garden sales (40% of biz). Stock lagged revenue peaks, with 2023-24 lows in the upper 20s despite steady equity growth, suggesting undervaluation.

Price ranges tell the volatility tale: 2022’s 28-42 reflected FCF woes, while 2024’s 32-47 captured recovery. Recent levels near 38 sit mid-range for 2025 (28-41), with upside if forecasts pan out.

Outlook: Steady Growth with Pet/Garden Tailwinds

Analysts foresee a rebound: revenue edging to $3.31 billion by 2028 (3% CAGR from 2025), net income +20% to $197 million, and shares shrinking to 62 million for EPS leverage. Capex rises to $66-68 million in 2026-27, likely for e-commerce or supply chain, but FCF should cover it. Risks? Pet humanization trends (premium foods) could boost, but competition from Chewy/Petco and weather-sensitive garden sales loom. Debt’s stable, but watch net debt if rates stay high.

For retail investors, CENT offers value—low multiples, improving cash flow, and 30%+ analyst upside— but insider sells and revenue flatness suggest patience. If you’re in pet stocks, this diversifies beyond pure plays; pair with macro pet spending data. Overall, a hold for growth seekers, buy on dips if margins confirm the turnaround. Keep an eye on Q1 2026 earnings for validation.